Tenaya Therapeutics earnings were -$105.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TNYA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$26.9M, up 12.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNYA reported annual earnings of -$111.1M, with -10.4% growth.
Tenaya Therapeutics Earnings Reports & History FAQ
What were Tenaya Therapeutics's earnings last quarter?
Tenaya Therapeutics (NASDAQ: TNYA) reported Q1 2025 earnings per share (EPS) of -$0.24, up 40% year over year. Total TNYA earnings for the quarter were -$26.86 million. In the same quarter last year, Tenaya Therapeutics's earnings per share (EPS) was -$0.40.
Is Tenaya Therapeutics profitable or losing money?
As of the last Tenaya Therapeutics earnings report, Tenaya Therapeutics is currently losing money. Tenaya Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$105.77 million, a 15.1% decrease year over year.
What was TNYA's earnings growth in the past year?
As of Tenaya Therapeutics's earnings date in Q2 2025, Tenaya Therapeutics's earnings has grown year over year. TNYA earnings in the past year totalled -$105.77 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.